Showing results (31-40 of 316) with videos related to
Sort By:
Pageof 32
ACS Medicinal Chemistry Letters|October 15, 2025
Development of Novel PET Tracers for Imaging Non-AD TauopathiesSteven H LiangACS Medicinal Chemistry Letters|July 16, 2025
Novel (1H‑Pyrazol-4-ylamino)pyrimidine Derivatives as Wee1 Inhibitors for Treatment of CancerSteven H LiangACS Medicinal Chemistry Letters|September 17, 2025
Chelator Optimization and Therapeutic Potential of 188Re-FAPI for FAP-Targeted Radionuclide TherapySteven H LiangAmerican Journal of Nuclear Medicine and Molecular Imaging|July 21, 2025
Trop2-targeted immunoPET ligandsSteven H LiangActa Pharmaceutica Sinica. B|September 23, 2024
Discovery and evaluation of a novel 18F-labeled vasopressin 1a receptor PET ligand with peripheral binding specificityJunqi Hu, Yinlong Li, Chenchen Dong, et al.ACS Medicinal Chemistry Letters|February 19, 2025
Imaging Alpha-synuclein with Novel 5H-Imidazo[1,5-b][1,2,4]triazole Radioligands for the Diagnosis of Parkinson's DiseaseZhendong Song, Steven H LiangACS Medicinal Chemistry Letters|March 18, 2026
Synthesis of Novel STING Antagonists and Their Uses in Treatment of STING Related DiseasesHaofeng Shi, Steven H LiangACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Quinazolinone Derivatives as Potent PARP1 InhibitorsXin Zhou, Steven H LiangACS Medicinal Chemistry Letters|February 18, 2026
Novel Werner Syndrome RecQ DNA Helicase (WRN) Inhibitors for Cancer TreatmentXin Zhou, Steven H LiangACS Medicinal Chemistry Letters|August 20, 2025
Novel Thieno[3,2‑b]Pyridine Derivatives in the Treatment of Huntington's DiseaseTaoqian Zhao, Steven H LiangPageof 32